These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 26268532)

  • 1. Restricted sedation and absence of cognitive impairments after administration of intranasal scopolamine.
    Weerts AP; Pattyn N; Putcha L; Hoag SW; Van Ombergen A; Hallgren E; Van de Heyning PH; Wuyts FL
    J Psychopharmacol; 2015 Dec; 29(12):1231-5. PubMed ID: 26268532
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intranasal scopolamine affects the semicircular canals centrally and peripherally.
    Weerts AP; Putcha L; Hoag SW; Hallgren E; Van Ombergen A; Van de Heyning PH; Wuyts FL
    J Appl Physiol (1985); 2015 Aug; 119(3):213-8. PubMed ID: 25953832
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of the effects of anti-motion sickness drugs on subjective sleepiness and cognitive performance of healthy males.
    Weerts AP; Pattyn N; Van de Heyning PH; Wuyts FL
    J Psychopharmacol; 2014 Jul; 28(7):655-64. PubMed ID: 24346808
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dose escalation pharmacokinetics of intranasal scopolamine gel formulation.
    Wu L; Boyd JL; Daniels V; Wang Z; Chow DS; Putcha L
    J Clin Pharmacol; 2015 Feb; 55(2):195-203. PubMed ID: 25187210
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The efficacy of low-dose intranasal scopolamine for motion sickness.
    Simmons RG; Phillips JB; Lojewski RA; Wang Z; Boyd JL; Putcha L
    Aviat Space Environ Med; 2010 Apr; 81(4):405-12. PubMed ID: 20377145
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transdermal scopolamine for prevention of motion sickness : clinical pharmacokinetics and therapeutic applications.
    Nachum Z; Shupak A; Gordon CR
    Clin Pharmacokinet; 2006; 45(6):543-66. PubMed ID: 16719539
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effects of transdermal scopolamine on simulated ship navigation and attention/reaction time.
    Howland J; Rohsenow DJ; Minsky S; Snoberg J; Tagerud S; Hunt SK; Almeida A; Greece J; Allensworth-Davies D
    Int J Occup Environ Health; 2008; 14(4):250-6. PubMed ID: 19043911
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effects of dimenhydrinate, cinnarizine and transdermal scopolamine on performance.
    Gordon CR; Gonen A; Nachum Z; Doweck I; Spitzer O; Shupak A
    J Psychopharmacol; 2001 Sep; 15(3):167-72. PubMed ID: 11565623
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Muscarinic and nicotinic receptors synergistically modulate working memory and attention in humans.
    Ellis JR; Ellis KA; Bartholomeusz CF; Harrison BJ; Wesnes KA; Erskine FF; Vitetta L; Nathan PJ
    Int J Neuropsychopharmacol; 2006 Apr; 9(2):175-89. PubMed ID: 15877932
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effects of the selective muscarinic M3 receptor antagonist darifenacin, and of hyoscine (scopolamine), on motion sickness, skin conductance & cognitive function.
    Golding JF; Wesnes KA; Leaker BR
    Br J Clin Pharmacol; 2018 Jul; 84(7):1535-1543. PubMed ID: 29522648
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intranasal Scopolamine for Motion Sickness.
    Stankovic AS; Alvarenga DL; Coleman Daniels VR; Simmons RG; Buckey JC; Putcha L
    Aerosp Med Hum Perform; 2019 Nov; 90(11):917-924. PubMed ID: 31666152
    [No Abstract]   [Full Text] [Related]  

  • 12. Effects of drug countermeasures for space motion sickness on working memory in humans.
    Paule MG; Chelonis JJ; Blake DJ; Dornhoffer JL
    Neurotoxicol Teratol; 2004; 26(6):825-37. PubMed ID: 15451046
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Overnight transdermal scopolamine patch administration has no clear effect on cognition and emotional processing in healthy volunteers.
    Bukala BR; Browning M; Cowen PJ; Harmer CJ; Murphy SE
    J Psychopharmacol; 2019 Feb; 33(2):255-257. PubMed ID: 30526264
    [TBL] [Abstract][Full Text] [Related]  

  • 14. RU 41,656 does not reverse the scopolamine-induced cognitive deficit in healthy volunteers.
    Patat A; Klein MJ; Surjus A; Hucher M; Granier J
    Eur J Clin Pharmacol; 1991; 41(3):225-31. PubMed ID: 1684155
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Muscarinic and nicotinic receptor modulation of object and spatial n-back working memory in humans.
    Green A; Ellis KA; Ellis J; Bartholomeusz CF; Ilic S; Croft RJ; Phan KL; Nathan PJ
    Pharmacol Biochem Behav; 2005 Jul; 81(3):575-84. PubMed ID: 15936063
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of chronic scopolamine administration on spatial working memory and hippocampal receptors related to learning.
    Doguc DK; Delibas N; Vural H; Altuntas I; Sutcu R; Sonmez Y
    Behav Pharmacol; 2012 Dec; 23(8):762-70. PubMed ID: 23080310
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exploratory pilot study assessing the risk of cognitive impairment or sedation in the elderly following single doses of solifenacin 10 mg.
    Wesnes KA; Edgar C; Tretter RN; Bolodeoku J
    Expert Opin Drug Saf; 2009 Nov; 8(6):615-26. PubMed ID: 19747069
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The use of effect sizes to characterize the nature of cognitive change in psychopharmacological studies: an example with scopolamine.
    Fredrickson A; Snyder PJ; Cromer J; Thomas E; Lewis M; Maruff P
    Hum Psychopharmacol; 2008 Jul; 23(5):425-36. PubMed ID: 18421801
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Estradiol treatment and its interaction with the cholinergic system: effects on cognitive function in healthy young women.
    Bartholomeusz CF; Wesnes KA; Kulkarni J; Vitetta L; Croft RJ; Nathan PJ
    Horm Behav; 2008 Nov; 54(5):684-93. PubMed ID: 18706905
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Scopolamine bioavailability in combined oral and transdermal delivery.
    Nachum Z; Shahal B; Shupak A; Spitzer O; Gonen A; Beiran I; Lavon H; Eynan M; Dachir S; Levy A
    J Pharmacol Exp Ther; 2001 Jan; 296(1):121-3. PubMed ID: 11123371
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.